At the moment, there are plenty of metrics market participants can use to monitor the equity markets. A pair of the most underrated are hedge fund and insider trading activity.
In today’s marketplace, there are plenty of gauges market participants can use to watch Mr. Market. Two of the most under-the-radar are hedge fund and insider trading interest.
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
XenoPort, Inc. (NASDAQ:XNPT) was in 13 hedge funds' portfolio at the end of December. XNPT investors should be aware of a decrease in activity from the world's largest hedge funds in recent months.